TG Therapeutics (TGTX)
(Delayed Data from NSDQ)
$22.83 USD
+0.65 (2.93%)
Updated Oct 14, 2024 03:59 PM ET
After-Market: $22.82 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 25% (73 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.63 | 1.67 | 9.99 |
Current Quarter Estimate | 0.03 | 6.92 | 63.00 |
Year Ago Quarter Estimate | 0.73 | 4.45 | 52.25 |
Next Quarter Estimate | 0.09 | 8.09 | 66.00 |
Next Year Estimate | 0.83 | 45.06 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 44.44 | 11.70 | 15.67 |
Next Year | 538.46 | 22.90 | 11.34 |
Last 5 Years | NA | 3.60 | 8.10 |
Next 5 Years | NA | 15.50 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 36.36 | 3.74 |
Price/Book (MRQ) | 19.30 | 2.16 |
Price/Cash Flow (MRFY) | 253.70 | 12.15 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 27.60% | 2.96% |
Return on Equity (TTM) | 57.73% | 7.87% |
Debt to Equity (MRQ) | NA | 26.16 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.